News
The Oticon email campaign is proof that the fundamentals of great marketing haven’t changed—only the format has. Seniors didn’t need clever subject lines or scarcity tactics. They needed a reason to ...
In Philadelphia, the leading causes of death are heart disease, cancer, and unintentional drug overdose. While some of these ...
UnitedHealth Group (UNH) stock gains marginally as the company names a new CEO for its health services division, Optum Health ...
2d
Stocktwits on MSNUnitedHealth Reshuffles Optum Execs As CEO Hemsley Takes Charge Of $105B DivisionUnitedHealth Group is making key leadership changes across its Optum health services business as Stephen Hemsley resumes his ...
UnitedHealth Group's health services segment, Optum Health, will be led by Patrick Conway, according to an internal company ...
UnitedHealth’s stock cuts the Dow’s price by more than 400 points, as care activity accelerates and Medicare costs remain higher than expected Last Updated: May 13, 2025 at 4:12 p.m. ET First ...
UnitedHealthcare is suing British newspaper The Guardian for defamation, alleging that the outlet falsely accused them of enticing nursing homes to enroll in a special program that works to ...
UnitedHeathcare claims in a lawsuit that The Guardian had knowlingly published false information and that it tried to capitalize on media interest the killing of its CEO Brian Thompson.
UnitedHealthcare sued The Guardian on Wednesday for defamation, claiming the British daily ran information it knew to be incorrect in order to “capitalize” on its CEO’s assassination.
UnitedHealth has denied the allegations, saying that the claims are false and have caused significant reputational damage. “This is unquestionably defamatory.
UnitedHealth investors approved a pay package for the returning chief executive that includes a $60 million stock option – even as the firm is plagued by financial losses, investigations and the ...
UnitedHealth added 800,000 Medicare Advantage members in Q1 FY 2025. Click here to find out why UNH stock is a Buy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results